- ALIAXIN® (6)
- ALIDYA™ (1)
- BCN (12)
- BELLAST® (3)
- BELOTERO® (8)
- BIOMEDICO (3)
- BIOREPEELCL3® (2)
- BRAUN (1)
- CAREGEN (2)
- CINGAL® (1)
- CRESPINE® (1)
- CROMA (4)
- CYTOCARE (4)
- DERMALAX™ (3)
- DESIRIAL® (2)
- DUROLANE® (1)
- EJAL (1)
- ELLANSÉ™ (2)
- EUFLEXXA® (1)
- EXOJUV (1)
- FILLMED® (10)
- FILORGA® (6)
- HArmonyCA™ (1)
- HYACORP (5)
- HYAFILIA® (2)
- HYALGAN® (1)
- HYMOVIS® (1)
- INTRALINE® (27)
- JALUPRO® (5)
- JUVÉDERM® (12)
- KARISMA (1)
- LANLUMA (1)
- LEMONBOTTLE (1)
- MEDIDERMA® (27)
- MESO-RELLE® (2)
- MESOESTETIC® (2)
- MONOVISC® (1)
- NEAUVIA™ (11)
- NEURAMIS® (1)
- NITHYA (3)
- NUCLEOFILL™ (8)
- ORTHOVISC® (1)
- PERFECTHA® (6)
- PLASMOLIFTING™ (1)
- PLINEST® (5)
- PROFHILO® (3)
- PROSTROLANE® (1)
- PRX-T33® (1)
- RADIESSE® (3)
- RAINBOW (7)
- REFINE (3)
- REJURAN® (3)
- RENEFIL (3)
- RESTYLANE® (10)
- REVANESSE® (6)
- REVOFIL (9)
- REVOLAX™ (4)
- SAYPHA® (6)
- SCULPTRA® (1)
- SESDERMA® (9)
- SILHOUETTE (3)
- SOFTFIL® (6)
- STYLAGE® (17)
- SUNEKOS® (4)
- SUPARTZ® (1)
- SYNVISC® (2)
- TEOSYAL® (13)
- THERASET® (1)
- ULTRA V® (1)
- VISCODERM® (2)
- ZO® (3)
Showing the single result
Manufacturer: Anika Therapeutics Active Substance(s): SODIUM…
What is Orthovisc?
Synovial fluid is the natural lubricant found in synovial joints. It cushions movement and helps bones glide smoothly. In osteoarthritis, this fluid loses its protective quality, which increases friction in the knee joint and other joints. This process often leads to stiffness, inflammation, and persistent joint pain. The Orthovisc injectable is designed to supplement this fluid and restore lubrication within the joint.
Orthovisc is an orthopedic injectable that contains highly purified sodium hyaluronate, a form of hyaluronic acid that mimics natural synovial fluid. Clinicians administer the Orthovisc injection directly into the knee through an intra-articular injection technique.
This medical therapy supports patients with symptomatic osteoarthritis by improving mobility and reducing inflammation in osteoarthritic joints. The product is manufactured by Anika Therapeutics, a developer of regenerative and orthopedic care products.
Core Clinical Features
-
Acts as a viscosupplement to improve lubrication in synovial joints
-
Designed for patients with chronic knee pain due to osteoarthritis
-
Administered as a series of orthopedic injections under sterile conditions
-
Classified as a locally acting drug with mechanical and biological effects
What Are The Benefits of This Minimally Invasive Treatment?
The Orthovisc injectable provides targeted relief without requiring surgical intervention. By restoring viscosity in the knee joint, it helps reduce friction between cartilage surfaces. This process decreases inflammation and improves movement in affected joints. Many patients report reduced pain and improved daily function after treatment.
Another advantage is the formulation itself. Orthovisc contains non–animal–derived hyaluronic acid, which supports tolerability and consistent performance. Because the therapy acts locally within the joint, it does not produce systemic effects typical of some oral medication options. This targeted action makes it a practical medical solution for the management of chronic osteoarthritis.
Clinical and Practical Advantages
-
Improves lubrication and shock absorption in the knee
-
Reduces stiffness and joint pain associated with degeneration
-
Minimally invasive compared with surgical procedures
-
Provides structured treatment through guided orthopedic injections
How Long Do The Results of These Hyaluronic Acid Injections Last?
The therapeutic effect of Orthovisc injection typically persists for several months. Clinical data and manufacturer guidance indicate symptom improvement may last up to 26 weeks in many cases.
Furthermore, the duration varies depending on disease severity, activity level, and overall joint health. Providers assess outcomes through functional improvement and reduction in knee pain.
Repeated treatment cycles may help maintain benefits in osteoarthritic joints. Physicians evaluate symptom progression, imaging findings, and response to prior therapy before recommending additional orthopedic injections.
Notably, consistent follow-up allows clinicians to tailor therapy for sustained relief and improved mobility.
Is There a Recovery Time Associated with Orthovisc?
Recovery following an Orthovisc injection is generally brief. Because clinicians administer the therapy directly into the knee joint, the procedure remains minimally invasive. Most patients resume routine activities shortly after treatment. Temporary swelling or localized discomfort at the injection site may occur but usually resolves quickly.
Providers typically advise limited weight-bearing and avoidance of strenuous activity for a short period after administration. This precaution supports optimal distribution of sodium hyaluronate within the joint.
Moreover, the absence of extensive downtime makes this medical therapy suitable for active individuals seeking non-surgical management of osteoarthritis.
Is Orthovisc Hyaluronic Acid Injection Safe?
Extensive clinical use supports the safety profile of the Orthovisc injectable when administered appropriately. The formulation is sterile, non-pyrogenic, and designed for intra-articular use. Because the therapy acts locally, systemic adverse reactions are uncommon. Healthcare professionals follow standardized medical protocols to reduce procedural risks.
Clinicians monitor patients for local reactions such as swelling or transient pain. Severe complications are rare when trained professionals perform the injection under sterile conditions. Providers also maintain readiness for emergency management of hypersensitivity reactions, although such events occur infrequently.
Orthovisc Side Effects
Most side effects associated with the Orthovisc injection are mild and localized. These reactions typically occur near the treated knee joint and resolve without intervention. Monitoring after orthopedic injections helps clinicians distinguish expected responses from complications.
Reported Adverse Effects
-
Temporary swelling or warmth at the injection site
-
Mild redness or bruising
-
Short-term increase in joint pain
-
Local inflammation in treated joints
Patients should report persistent symptoms or unexpected reactions to their provider promptly.
Contraindications
Orthovisc therapy is not appropriate for all individuals. Providers must review patient history and perform clinical evaluation before initiating treatment. Certain conditions increase the risk of complications in synovial joints receiving viscosupplementation.
Contraindicated situations
-
Active infection within the target joint
-
Skin disease or infection at the injection site
-
Known hypersensitivity to sodium hyaluronate components
-
Certain bleeding disorders affecting procedural safety
Clinicians should review the official product information and prescribing guidance before use. Careful patient selection supports safe and effective outcomes.
Where To Buy Orthovisc Online
Licensed providers can order Orthovisc through authorized distributors that supply regulated medical products and clinical supplies. Procurement requires a valid prescription and adherence to storage and handling standards. Reliable distribution channels help maintain product integrity and traceability throughout the supply chain.
Clinics often compare inventory availability and price structures when sourcing viscosupplementation therapies. Transparent procurement processes support treatment planning for osteoarthritis care in outpatient and specialty settings.
Purchase Orthovisc Medication At Medica Depot
Practices may obtain Orthovisc through authorized distributors such as Medica Depot. Working with an established supplier helps streamline procurement of orthopedic supplies and maintain consistent inventory levels. Verified distributors provide product documentation, handling guidance, and updated information for clinical use.
Reliable sourcing also supports efficient practice management. Providers can coordinate order scheduling, confirm availability of Orthovisc injectable formats, and review current price options.
Structured purchasing processes ensure continuity of care for patients receiving viscosupplementation therapy for chronic knee pain.